Microfluidic Tissue Screening for Sample Preparation Optimization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing biological assays for tissue analysis, such as ISH, FISH, DBIT-seq, scRNA-seq, and snRNA-seq, are time-consuming and resource-intensive due to variations in tissue preparation conditions, reagent performance, and tissue sample quality, which affect analyte amount, quality, and accessibility, necessitating a high throughput screening method to optimize these factors.

Innovation Solution

A microfluidic chip with multiple channels is used to apply varying reagents to different regions of a tissue sample, capturing images before and after reagent interaction, and analyzing the results to determine optimal preparation conditions, thereby marginalizing over biological variations and reducing the need for multiple tissue samples.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If multiple tissue samples are used to test different reagent concentrations, then statistical account for sample-to-sample variation is achieved, but the number of separate experiments increases significantly

Engineering Contradiction:
Improvestatistical accuracyVSAvoidoptimization time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent combines multiple experimental conditions (different reagent concentrations) onto a single tissue section by using a microfluidic device with multiple channels. Each channel applies a different reagent concentration to a specific region of the same tissue section, allowing simultaneous testing of multiple conditions without requiring multiple separate tissue samples or experiments.

Inventive Principle:
Principle #5Merging (Combining)

2Measurement precision

If many reagent concentrations are tested on separate tissue samples, then optimal concentration is identified, but the quantity of tissue samples required increases

Engineering Contradiction:
Improveoptimal condition identificationVSAvoidtissue sample consumption
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The patent segments the tissue section into multiple regions, with each region exposed to a different reagent concentration through dedicated microfluidic channels. This segmentation allows parallel testing of multiple conditions on a single tissue section, dramatically reducing the total number of tissue samples needed while maintaining the ability to identify optimal conditions.

Inventive Principle:
Principle #1Segmentation

3Stability of the object's composition

If traditional single-concentration permeabilization is used, then cellular integrity is maintained, but probe accessibility to analytes is limited

Engineering Contradiction:
Improvecellular integrityVSAvoidassay performance
Core Design Contradiction:
Stability of the object's compositionVSReliability

Solution Approach 1:

The patent systematically varies the concentration parameter of permeabilization reagents across different channels of the microfluidic device. By testing a range of concentrations (from low to high) on the same tissue section, the method identifies the optimal concentration that achieves the right balance between maintaining cellular integrity and enabling sufficient probe accessibility for reliable assay performance.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method allows for rapid, cost-effective optimization of tissue preparation conditions, improving assay performance by minimizing sample usage and reducing optimization time, while providing a quality control assay for downstream analyses.

Implementation Method 1

A microfluidic chip with multiple channels is used to apply varying reagents to different regions of a tissue sample

Methodology Applied
Scientific EffectMicrofluidics:

Implementation Method 2

optically marking the tissue sample to identify a quality of the tissue sample and areas in the tissue sample affected by the flow of the plurality of reagents

Methodology Applied
Scientific EffectOptical marking:

Data Source

PatentUS12497652B2System and methods for high throughput screening of tissue preparation conditions
Publication Date: 2025.12.16 ATLASXOMICS INC
  • US12497652B2 patent drawing
  • US12497652B2 patent drawing
  • US12497652B2 patent drawing

AI summary

The present disclosure relates generally to systems and methods for screening sample preparation conditions and, more specifically, high throughput screening of tissue sample preparation conditions.